Pfizer's Zavzpret was approved by FDA to treat migraine

Pfizer’s ZAVZPRET Migraine Nasal Spray InfoПодробнее

FDA approves Prizer's Zavzpret, first-of-its-kind migraine treatment nasal sprayПодробнее

FDA approves new nasal spray to treat migraine headachesПодробнее

FDA approves new nasal spray to treat migraine headaches in adults, Pfizer saysПодробнее

Zavegepant: an acute treatment option for migraineПодробнее

FDA approves new nasal spray to treat migraine headaches in adults, Pfizer saysПодробнее

New FDA-approved nasal spray to treat migraine headaches hits shelves in JulyПодробнее

FDA approves nasal spray for migrainesПодробнее

1st nasal spray treatment of its kind for migraines gets FDA approvalПодробнее

FDA approves new nasal spray for migrainesПодробнее

New Treatment for Migraine Approved by FDA: Zavegepant (Zavzpret)Подробнее

FDA approves at-home nasal spray flu vaccine for 2025 releaseПодробнее

AHS highlights: atogepant and zavegepant for migraine treatmentПодробнее

FDA approves nasal spray for migrainesПодробнее

Zavegepant nasal spray for the acute treatment of migraine with and without auraПодробнее

FDA approves nasal spray to treat migrainesПодробнее

Pfizer's nasal spray for migraines and impacts of sleep | NewsNation LiveПодробнее

Prevent and Treat Migraines with CEFALY® - FSA/HSA Eligible FDA Approved Drug Free Migraine DeviceПодробнее

New nasal spray for migraines could be available at pharmacies in JulyПодробнее

New options, relief for those who suffer from migrainesПодробнее

FDA approves new nasal spray offering relief for migraine patientsПодробнее